{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:31:32Z","timestamp":1777419092596,"version":"3.51.4"},"reference-count":63,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To review the pharmacology, pharmacokinetics, safety, and pivotal clinical trials for natalizumab in the treatment of multiple sclerosis (MS) and inflammatory bowel disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES<\/jats:title>\n                    <jats:p>A PubMed\/MEDLINE search was conducted (1966\u2013June 2005), and information was obtained from Iowa Drug Information Services. Additional data sources included meeting abstracts, bibliographies from identified articles, and information from the manufacturer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION AND DATA EXTRACTION<\/jats:title>\n                    <jats:p>Studies and review articles examining natalizumab were evaluated. All published, randomized clinical trials evaluating natalizumab in MS and IBD were included in this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS<\/jats:title>\n                    <jats:p>Natalizumab is the first drug in a new class of agents called selective adhesion molecule inhibitors. It has shown promising results in MS and inflammatory bowel disease and appears superior compared with current therapies in reducing relapse rates. However, 3 recent, confirmed case reports of progressive multifocal leukoencephalopathy (PML) create concern about natalizumab's use in combination with existing therapies or in undefined patient subgroups. Natalizumab was voluntarily withdrawn from the market in March 2005 while the drug's safety is further evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Although long-term efficacy and safety of natalizumab have not been established, available data indicate that it is a novel drug for patients with MS or inflammatory bowel disease. Analysis of its possible association with PML will determine the risk\u2013benefit evaluation and eventual place in therapy for natalizumab.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1g134","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T23:23:42Z","timestamp":1129073022000},"page":"1833-1843","source":"Crossref","is-referenced-by-count":22,"title":["Natalizumab for the Treatment of Multiple Sclerosis and Crohn's Disease"],"prefix":"10.1177","volume":"39","author":[{"given":"Kendra A","family":"Keeley","sequence":"first","affiliation":[{"name":"Kendra A Keeley PharmD, at time of writing, Pharmacy Practice Resident, The University of Montana and Community Medical Center, Missoula, MT; now, Clinical Specialist, IPHARM (ImProving Health Among Rural Montanans) project, University of Montana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P","family":"Rivey","sequence":"additional","affiliation":[{"name":"Michael P Rivey MS BCPS, Professor of Pharmacy Practice, School of Pharmacy, The University of Montana; Clinical Pharmacy Consultant, Community Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R","family":"Allington","sequence":"additional","affiliation":[{"name":"Douglas R Allington PharmD BCPS, Associate Professor of Pharmacy Practice, School of Pharmacy, The University of Montana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"bibr1-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00505-2"},{"key":"bibr2-aph.1G134","first-page":"4","author":"Smith CH","year":"2004","journal-title":"Formulary"},{"key":"bibr3-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1080\/00855910310001467"},{"key":"bibr4-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200207000-00009"},{"key":"bibr5-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01965.x"},{"key":"bibr6-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08703.x"},{"key":"bibr7-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.4.4.571"},{"key":"bibr8-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.062"},{"key":"bibr9-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(98)01287-9"},{"key":"bibr10-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90491-3"},{"key":"bibr11-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010053431407"},{"key":"bibr12-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00084-3"},{"key":"bibr13-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607043350108"},{"key":"bibr14-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606063342308"},{"issue":"2","key":"bibr15-aph.1G134","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.62.suppl_2.ii70","volume":"62","author":"Ghosh S","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"bibr16-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90233-9"},{"key":"bibr17-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/S1367-5931(98)80120-8"},{"key":"bibr18-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2000.025.09.593332"},{"key":"bibr19-aph.1G134","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200405020-00007"},{"key":"bibr20-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe020157"},{"key":"bibr21-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2001.026.10.858716"},{"key":"bibr22-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#"},{"key":"bibr23-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1084oa"},{"key":"bibr24-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)00165-K"},{"key":"bibr25-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116575"},{"key":"bibr26-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020696"},{"key":"bibr27-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020732"},{"key":"bibr28-aph.1G134","volume-title":"Package insert. Tysabri (natalizumab)","year":"2004"},{"key":"bibr29-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01205.x"},{"issue":"3","key":"bibr30-aph.1G134","first-page":"A259","volume":"54","author":"Carter JL","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"bibr31-aph.1G134","first-page":"A-434","volume":"122","author":"Van Deventer S","year":"2002","journal-title":"Gastroenterology"},{"key":"bibr32-aph.1G134","first-page":"685","volume":"27","author":"Cuellell-Young M","year":"2002","journal-title":"Drugs Future"},{"key":"bibr33-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000128136.79044.D6"},{"key":"bibr34-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.5.1072"},{"key":"bibr35-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26260"},{"issue":"4","key":"bibr36-aph.1G134","doi-asserted-by":"crossref","first-page":"A-874","DOI":"10.1016\/S0016-5085(00)85637-1","volume":"118","author":"Feagan BG","year":"2000","journal-title":"Gastroenterology"},{"key":"bibr37-aph.1G134","first-page":"S61","volume":"8","author":"Bennett D","year":"2002","journal-title":"Multiple Sclerosis"},{"issue":"4","key":"bibr38-aph.1G134","first-page":"A-434","volume":"122","author":"Gordon FH","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"bibr39-aph.1G134","first-page":"A-211","volume":"126","author":"Lawrance IC","year":"2004","journal-title":"Gastroenterology"},{"key":"bibr40-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"bibr41-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.466"},{"key":"bibr42-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"bibr43-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.10.1368"},{"issue":"2","key":"bibr44-aph.1G134","first-page":"S32","volume":"243","author":"Sharrack B","year":"1996","journal-title":"Neurology"},{"key":"bibr45-aph.1G134","first-page":"1","volume":"3","author":"Minagar A","year":"2000","journal-title":"Mar"},{"key":"bibr46-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(76)80163-1"},{"key":"bibr47-aph.1G134","doi-asserted-by":"publisher","DOI":"10.3109\/00365527809182199"},{"key":"bibr48-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90585-1"},{"issue":"4","key":"bibr49-aph.1G134","first-page":"A76","volume":"126","author":"Sandborn WJ","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"bibr50-aph.1G134","first-page":"A462","volume":"126","author":"Enns RA","year":"2004","journal-title":"Gastroenterology"},{"key":"bibr51-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.009"},{"key":"bibr52-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117519"},{"key":"bibr53-aph.1G134","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.9.4514"},{"key":"bibr54-aph.1G134","first-page":"236","volume":"9","author":"Pankaj S","year":"2003","journal-title":"J Neurol"},{"key":"bibr55-aph.1G134","volume-title":"Questions and answers on natalizumab (marketed as Tysabri)"},{"key":"bibr56-aph.1G134","volume-title":"Suspended marketing of Tysabri (natalizumab)"},{"key":"bibr57-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051847"},{"key":"bibr58-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"bibr59-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051586"},{"key":"bibr60-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe058122"},{"key":"bibr61-aph.1G134","unstructured":"61. Reuters Health Information. Possible fifth Tysabri-related case\u2014WSJ. June 2005. www.medscape.com\/viewarticle\/506496 (accessed 2005 Jun 14)."},{"key":"bibr62-aph.1G134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc055235"},{"key":"bibr63-aph.1G134","first-page":"D5","volume":"1","author":"Armstrong D","year":"2005","journal-title":"Wall Street Journal."}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1G134","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1345\/aph.1G134","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1G134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:09:21Z","timestamp":1777374561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1G134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1345\/aph.1G134"],"URL":"https:\/\/doi.org\/10.1345\/aph.1g134","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}